Literature DB >> 21358460

Normative data set identifying properties of the macula across age groups: integration of visual function and retinal structure with microperimetry and spectral-domain optical coherence tomography.

Felix N Sabates1, Ryan D Vincent, Peter Koulen, Nelson R Sabates, Gary Gallimore.   

Abstract

PURPOSE: A normative database of functional and structural parameters of the macula from normal subjects was established to identify reference points for the diagnosis of patients with macular disease using microperimetry and scanning laser ophthalmoscope/spectral-domain optical coherence tomography (SD-OCT).
METHODS: This was a community-based, prospective, cross-sectional study of 169 eyes from subjects aged 21 years to 85 years with best-corrected visual acuity of 20/25 or better and without any ocular disease. Full-threshold macular microperimetry combined with the acquisition of structural parameters of the macula with scanning laser ophthalmoscope/SD-OCT was recorded (SD-OCT/scanning laser ophthalmoscope with add-on Microperimetry module; OPKO). Fixation, central, subfield, and mean retinal thickness were acquired together with macular sensitivity function. Thickness and sensitivity as primary outcome measures were mapped and superimposed correlating topographically differentiated macular thickness with sensitivity. Statistical evaluation was performed with age, gender, and ethnicity as covariates.
RESULTS: Subfield and mean retinal thickness and sensitivity were measured with macular microperimetry combined with SD-OCT and differentiated by macular topography and subjects' age, gender, and ethnicity. Mean retinal sensitivity and thickness were calculated for 169 healthy eyes (mean age, 48 ± 17 years). A statistically significant decrease in sensitivity was found only in the age group of participants ≥ 70 years and in peripheral portions of the macula in individuals aged ≥60 years and was more pronounced in the area surrounding the fovea than in the center of the macula, while retinal thickness did not change with age. No statistically significant differences in the primary outcome measures or their correlations were found when using gender or ethnicity as a covariate.
CONCLUSION: A database for normal macular thickness and sensitivity was generated with a combined microperimetry SD-OCT system as the basis for comparison of outcome parameters in patients with macular abnormality. Mean retinal sensitivity decreased significantly only in the age group of participants ≥ 70 years and in peripheral portions of the macula in individuals aged ≥60 years, with increasing distance from the fovea, while other parameters, their correlations and covariates, were not affected within the normative data set. No relationship was detected between retinal thickness and retinal sensitivity in the healthy macula.

Entities:  

Mesh:

Year:  2011        PMID: 21358460     DOI: 10.1097/IAE.0b013e3182019be2

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  14 in total

1.  FELLOW EYE CHANGES IN PATIENTS WITH NONISCHEMIC CENTRAL RETINAL VEIN OCCLUSION: Assessment of Perfused Foveal Microvascular Density and Identification of Nonperfused Capillaries.

Authors:  Alexander Pinhas; Michael Dubow; Nishit Shah; Eric Cheang; Chun L Liu; Moataz Razeen; Alexander Gan; Rishard Weitz; Yusufu N Sulai; Toco Y Chui; Alfredo Dubra; Richard B Rosen
Journal:  Retina       Date:  2015-10       Impact factor: 4.256

2.  Fundus-controlled two-color dark adaptometry with the Microperimeter MP1.

Authors:  Wadim Bowl; Knut Stieger; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-24       Impact factor: 3.117

3.  Atypical retinotopic organization of visual cortex in patients with central brain damage: congenital and adult onset.

Authors:  Danielle C Reitsma; Jedidiah Mathis; John L Ulmer; Wade Mueller; Mary J Maciejewski; Edgar A DeYoe
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

4.  Assessment of Central Retinal Sensitivity Employing Two Types of Microperimetry Devices.

Authors:  Hongting Liu; Millena G Bittencourt; Jiangxia Wang; Raafay Sophie; Rachel Annam; Mohamed A Ibrahim; Yasir J Sepah; Ahmadreza Moradi; Hendrik P N Scholl; Quan Dong Nguyen
Journal:  Transl Vis Sci Technol       Date:  2014-09-12       Impact factor: 3.283

5.  Retinal Thickness Normative Data in Wild-Type Mice Using Customized Miniature SD-OCT.

Authors:  Lee R Ferguson; James M Dominguez; Sankarathi Balaiya; Sandeep Grover; Kakarla V Chalam
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

6.  Macular thickness measurements using Copernicus Spectral Domain Optical Coherence Tomography.

Authors:  Laxmi Gella; Rajiv Raman; Tarun Sharma
Journal:  Saudi J Ophthalmol       Date:  2014-10-18

7.  Clinical application of optical coherence tomography in combination with functional diagnostics: advantages and limitations for diagnosis and assessment of therapy outcome in central serous chorioretinopathy.

Authors:  Joshua A Schliesser; Gary Gallimore; Nancy Kunjukunju; Nelson R Sabates; Peter Koulen; Felix N Sabates
Journal:  Clin Ophthalmol       Date:  2014-11-21

8.  Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's disease.

Authors:  Ewa Langwińska-Wośko; Tomasz Litwin; Kamil Szulborski; Anna Członkowska
Journal:  Metab Brain Dis       Date:  2015-12-21       Impact factor: 3.584

9.  Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials.

Authors:  Albert Caramoy; Jonathan Foerster; Elvira Allakhiarova; Carel B Hoyng; Katharina Dröge; Bernd Kirchhof; Sascha Fauser
Journal:  Br J Ophthalmol       Date:  2012-08-03       Impact factor: 4.638

10.  Pattern Recognition Analysis Reveals Unique Contrast Sensitivity Isocontours Using Static Perimetry Thresholds Across the Visual Field.

Authors:  Jack Phu; Sieu K Khuu; Lisa Nivison-Smith; Barbara Zangerl; Agnes Yiu Jeung Choi; Bryan W Jones; Rebecca L Pfeiffer; Robert E Marc; Michael Kalloniatis
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.